文献速递头颈技术与安全MRPET

头颈癌18F-FDG-PET/MRI肿瘤勾画中是否需要钆增强MR序列

Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous 18F-FDG-PET/MRI for Tumor Delineation in Head and Neck Cancer?
PubMed 文献 · AJNR Am J Neuroradiol · 2020-09-24

回顾性纳入30例头颈癌患者,比较无增强与增强T1WI序列在18F-FDG-PET/MRI上对45个解剖区域肿瘤侵犯和淋巴结转移的评估,与病理对照。两种读片方案诊断准确率均为0.97,敏感度和特异度无差异,钆增强序列未显示附加价值。

要点

  • 无增强与增强读片对肿瘤范围判断一致性极好(κ=0.96)。
  • 两种读片方案诊断准确率均为0.97,敏感度0.83-0.90,特异度0.98。
  • 钆增强序列在头颈癌PET/MRI肿瘤勾画中未显示附加价值。

核心结论

  • 钆螯合物增强对头颈癌原发肿瘤范围及淋巴结转移的准确评估未显示附加价值,在PET/MRI头颈工作流程中可能可以避免使用。

研究设计与样本

  • 回顾性纳入连续接受同期头颈18F-FDG-PET/MRI分期或再分期后手术的患者30例。
  • 由2组阅片者(每组包括1名放射科医生和1名核医学医生)在45个头颈解剖区域评估局部肿瘤侵犯和淋巴结延伸。
  • 进行两次读片:第一次仅用T1WI、T2WI和PET图像(无增强),第二次附加T1WI增强后序列;以详细组织病理学分析为参考标准。

关键影像表现/征象

  • 无增强与增强读片在45个解剖区域勾画精确肿瘤延伸的一致性极好(Cohen κ=0.96,95% CI=[0.94-0.97],P<.001)。

诊断标准与关键数值

  • 无增强与增强读片诊断准确率均为0.97,两组阅片者、两次读片均相同。
  • 无增强读片敏感度分别为0.83和0.85,增强读片敏感度分别为0.88和0.90(两组阅片者)。
  • 两组阅片者、两次读片特异度均为0.98。

临床应用与阅片要点

  • 作者认为钆增强序列在头颈癌PET/MRI肿瘤勾画中未显示附加价值,可能可以避免使用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: PET/MRI with 18F-FDG has demonstrated the advantages of simultaneous PET and MR imaging in head and neck cancer imaging, MRI allowing excellent soft-tissue contrast, while PET provides metabolic information. The aim of this study was to evaluate the added value of gadolinium contrast-enhanced sequences in the tumor delineation of head and neck cancers on 18F-FDG-PET/MR imaging.

MATERIALS AND METHODS: Consecutive patients who underwent simultaneous head and neck 18F-FDG-PET/MR imaging staging or restaging followed by surgery were retrospectively included. Local tumor invasion and lymph node extension were assessed in 45 head and neck anatomic regions using 18F-FDG-PET/MR imaging by 2 rater groups (each one including a radiologist and a nuclear medicine physician). Two reading sessions were performed, one without contrast-enhanced sequences (using only T1WI, T2WI, and PET images) and a second with additional T1WI postcontrast sequences. The results were compared with the detailed histopathologic analysis, used as reference standard. The κ concordance coefficient between the reading sessions and sensitivity and specificity for each region were calculated.

RESULTS: Thirty patients were included. There was excellent agreement between the contrast-free and postgadolinium reading sessions in delineating precise tumor extension in the 45 anatomic regions studied (Cohen κ = 0.96, 95% CI = [0.94-0.97], P < .001). The diagnostic accuracy did not differ between contrast-free and postgadolinium reading sessions, being 0.97 for both groups and both reading sessions. For the 2 rater groups, there was good sensitivity for both contrast-free (0.83 and 0.85) and postgadolinium reading sessions (0.88 and 0.90, respectively). Moreover, there was excellent specificity (0.98) for both groups and reading sessions.

CONCLUSIONS: Gadolinium chelate contrast administration showed no added value for accurate characterization of head and neck primary tumor extension and could possibly be avoided in the PET/MR imaging head and neck workflow.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Pyatigorskaya N, De Laroche R, Bera G, et al. Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous 18F-FDG-PET/MRI for Tumor Delineation in Head and Neck Cancer? AJNR Am J Neuroradiol. 2020. PMID: 32972956. doi:10.3174/ajnr.A6764

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。